ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and efficacy of ALKS 37 when administered daily to adults with OIC.

Phase 2

Alkermes, Inc.